Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NVS

Novartis

$80.84

-0.05 (-0.06%)

12:20
07/19/18
07/19
12:20
07/19/18
12:20
Options
Novartis option volume is 9X daily average as calls see interest after earnings »

Novartis option volume is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$37.37

-0.29 (-0.77%)

, MYL

Mylan

$35.60

-0.33 (-0.92%)

12:06
07/19/18
07/19
12:06
07/19/18
12:06
Periodicals
FDA commissioner criticizes drug makers for stalling biosimilars, STAT says »

Scott Gottlieb, the…

PFE

Pfizer

$37.37

-0.29 (-0.77%)

MYL

Mylan

$35.60

-0.33 (-0.92%)

NVS

Novartis

$80.79

-0.1 (-0.12%)

TEVA

Teva

$23.13

-0.41 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

  • 16

    Sep

  • 13

    Nov

AGN

Allergan

$173.01

-2.84 (-1.62%)

, NVS

Novartis

$80.75

-0.14 (-0.17%)

11:41
07/19/18
07/19
11:41
07/19/18
11:41
Recommendations
Allergan, Novartis, Regeneron analyst commentary at Wells Fargo »

Allergan wet AMD data…

AGN

Allergan

$173.01

-2.84 (-1.62%)

NVS

Novartis

$80.75

-0.14 (-0.17%)

REGN

Regeneron

$366.46

0.57 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 26

    Jul

  • 11

    Aug

  • 20

    Oct

  • 28

    Oct

NVS

Novartis

$80.89

2.17 (2.76%)

08:57
07/19/18
07/19
08:57
07/19/18
08:57
Upgrade
Novartis rating change at Barclays »

Novartis upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.89

2.17 (2.76%)

, PFE

Pfizer

$37.66

-0.01 (-0.03%)

06:31
07/19/18
07/19
06:31
07/19/18
06:31
Hot Stocks
Trump says 'thank you' to Novartis, Pfizer for not increasing drug prices »

President Donald Trump…

NVS

Novartis

$80.89

2.17 (2.76%)

PFE

Pfizer

$37.66

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

NVS

Novartis

$80.89

2.17 (2.76%)

, GLPG

Galapagos NV

$102.08

-0.76 (-0.74%)

05:47
07/19/18
07/19
05:47
07/19/18
05:47
Hot Stocks
Novartis announces exclusive license agreement with Galapagos, MorphoSys »

Novartis (NVS) announced…

NVS

Novartis

$80.89

2.17 (2.76%)

GLPG

Galapagos NV

$102.08

-0.76 (-0.74%)

MOR

MorphoSys

$32.92

0.41 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Yesterday
NVS

Novartis

$80.55

1.83 (2.32%)

13:12
07/18/18
07/18
13:12
07/18/18
13:12
Periodicals
Novartis considering range of options for Sandoz generics unit, Bloomberg says »

Novartis is evaluating a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.56

1.84 (2.34%)

, TEVA

Teva

$23.46

0.32 (1.38%)

13:11
07/18/18
07/18
13:11
07/18/18
13:11
Recommendations
Novartis, Teva, Mylan, Pfizer, Amgen, Eli Lilly analyst commentary at Wells Fargo »

Novartis report has…

NVS

Novartis

$80.56

1.84 (2.34%)

TEVA

Teva

$23.46

0.32 (1.38%)

MYL

Mylan

$36.02

-0.35 (-0.96%)

PFE

Pfizer

$37.61

-0.06 (-0.16%)

AMGN

Amgen

$193.01

-0.92 (-0.47%)

LLY

Eli Lilly

$90.07

0.5 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 08

    Aug

  • 22

    Aug

  • 10

    Sep

  • 16

    Sep

  • 13

    Nov

NVS

Novartis

$80.86

2.14 (2.72%)

11:35
07/18/18
07/18
11:35
07/18/18
11:35
Hot Stocks
Novartis Kisqali only CDK4/6 inhibitor indicated in US as first-line therapy »

Novartis announced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$78.72

0.15 (0.19%)

, PFE

Pfizer

$37.67

0.28 (0.75%)

06:24
07/18/18
07/18
06:24
07/18/18
06:24
Periodicals
Novartis puts brakes on price hikes in the U.S. for 2018, Reuters reports »

Novartis (NVS) CEO Vas…

NVS

Novartis

$78.72

0.15 (0.19%)

PFE

Pfizer

$37.67

0.28 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.